Abstract
The purpose of this study was to investigate factors associated with AF in patients with hyperthyroidism beyond heart failure (HF), coronary heart disease (CHD), or valvular diseases. A total of 136 patients (mean age, 52 ± 15 years; 86 [63%] female) who were diagnosed with hyperthyroidism for the first time were enrolled. Patients who had HF, CHD, or significant valvular diseases were excluded. Patients were classified into two groups according to the presence (group 1, n = 40) and absence of AF (group 2, n = 96). AF occurred in 40 (29%) patients and 23 (58%) of these patients showed paroxysmal AF. Among the symptoms of hyperthyroidism, the most common chief complaint was palpitation (30%). Advanced age, presence of prior cerebrovascular events, and presence of palpitations were associated with AF. Larger left atrial volume index (LAVI), increased left ventricular mass index, and decreased left ventricular ejection fraction (LVEF) and S′ velocity were associated with AF. Among them, presence of palpitations and increased LAVI were independently associated with the occurrence of AF. In addition, strain analysis, decreased LA expansion index (EI), ejection fraction (EF), peak atrial longitudinal strain, contraction strain, and late diastolic strain rate (A sr) and systolic strain rate (S sr) were associated with the occurrence of AF and LAVI. Presence of palpitations and enlarged left atrium were associated with the occurrence of AF in patients with hyperthyroidism irrespective of conventional risk factors. Additional LA analysis revealed that decreased LA function was associated with AF and enlarged left atrium.
Similar content being viewed by others
References
Wasmer K, Eckardt L, Breithardt G (2017) Predisposing factors for atrial fibrillation in the elderly. J Geriatr Cardiol 14:179–184
Staerk L, Sherer JA, Ko D, Benjamin EJ, Helm RH (2017) Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes. Circ Res 120:1501–1517
Goudis CA, Korantzopoulos P, Ntalas IV, Kallergis EM, Ketikoglou DG (2015) Obesity and atrial fibrillation: a comprehensive review of the pathophysiological mechanisms and links. J Cardiol 66:361–369
Shapira-Daniels A, Mohanty S, Contreras-Valdes FM, Tieu H, Thomas RJ, Natale A et al (2020) Prevalence of undiagnosed sleep apnea in patients with atrial fibrillation and its impact on therapy. JACC Clin Electrophysiol 6:1499–1506
Voskoboinik A, Prabhu S, Ling LH, Kalman JM, Kistler PM (2016) Alcohol and atrial fibrillation: a sobering review. J Am Coll Cardiol 68:2567–7256
Lubitz SA, Yin X, Rienstra M, Schnabel RB, Walkey AJ, Magnani JW et al (2015) Long-term outcomes of secondary atrial fibrillation in the community: the Framingham Heart Study. Circulation 131:1648–1655
Vahdatpour CA, Luebbert JJ, Palevsky HI (2020) Atrial arrhythmias in chronic lung disease-associated pulmonary hypertension. Pulm Circ 10:2045894020910685
Woeber KA (1992) Thyrotoxicosis and the heart. N Engl J Med 327:94–98
Reddy V, Taha W, Kundumadam S, Khan M (2017) Atrial fibrillation and hyperthyroidism: a literature review. Indian Heart J 69:545–550
Wustmann K, Kucera JP, Zanchi A, Burow A, Stuber T, Chappuis B et al (2008) Activation of electrical triggers of atrial fibrillation in hyperthyroidism. J Clin Endocrinol Metab 93:2104–2108
Klein I, Danzi S (2007) Thyroid disease and the heart. Circulation 116:1725–1735
Markides V, Schilling RJ (2003) Atrial fibrillation: classification, pathophysiology, mechanisms and drug treatment. Heart 89:939–943
Watanabe H, Ma M, Washizuka T, Komura S, Yoshida T, Hosaka Y et al (2003) Thyroid hormone regulates mRNA expression and currents of ion channels in rat atrium. Biochem Biophys Res Commun 308:439–444
Bielecka-Dabrowa A, Mikhailidis DP, Rysz J, Banach M (2009) The mechanisms of atrial fibrillation in hyperthyroidism. Thyroid Res 2:4
Klein I, Ojamaa K (2001) Thyroid hormone and the cardiovascular system. N Engl J Med 344:501–509
Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28:1–39
Hsiao SH, Huang WC, Lin KL, Chiou KR, Kuo FY, Lin SK et al (2010) Left atrial distensibility and left ventricular filling pressure in acute versus chronic severe mitral regurgitation. Am J Cardiol 105:709–715
Hoit BD (2014) Left atrial size and function: role in prognosis. J Am Coll Cardiol 63:493–505
Cameli M, Lisi M, Righini FM, Mondillo S (2012) Novel echocardiographic techniques to assess left atrial size, anatomy and function. Cardiovasc Ultrasound 10:4
Frost L, Vestergaard P, Mosekilde L (2004) Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study. Arch Intern Med 164:1675–1678
Auer J, Scheibner P, Mische T, Langsteger W, Eber O, Eber B (2001) Subclinical hyperthyroidism as a risk factor for atrial fibrillation. Am Heart J 142:838–842
Hiss RG, Lamb LE (1962) Electrocardiographic findings in 122,043 individuals. Circulation 25:947–965
Ghandour A, Reust C (2011) Hyperthyroidism: a stepwise approach to treatment. J Fam Pract 60:388–395
Palitzsch KD (2008) Prevention and multimodal therapy of hyperthyroidism. Internist (Berl) 49:1428–1436
Ertek S, Cicero AF (2013) Hyperthyroidism and cardiovascular complications: a narrative review on the basis of pathophysiology. Arch Med Sci 9:944–952
Klein I, Ojamaa K (1998) Thyrotoxicosis and the heart. Endocrinol Metab Clin N Am 27:51–62
Nordyke RA, Gilbert FI Jr, Harada ASM (1988) Graves’ disease: influence of age on clinical findings. Arch Intern Med 148:626–631
Krahn AD, Klein GJ, Kerr CR, Boone J, Sheldon R, Green M et al (1996) How useful is thyroid function testing in patients with recent-onset atrial fibrillation? Arch Intern Med 156:2221–2224
Henry WL, Morganroth J, Pearlman AS, Clark CE, Redwood DR, Itscoitz SB et al (1976) Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation 53:273–279
Seko Y, Kato T, Haruna T, Izumi T, Miyamoto S, Nakane E et al (2018) Association between atrial fibrillation, atrial enlargement, and left ventricular geometric remodeling. Sci Rep 8:6366
Abhayaratna WP, Seward JB, Appleton CP, Douglas PS, Oh JK, Tajik AJ et al (2006) Left atrial size: physiologic determinants and clinical applications. J Am Coll Cardiol 47:2357–2363
Cuspidi C, Rescaldani M, Sala C (2013) Prevalence of echocardiographic left-atrial enlargement in hypertension: a systematic review of recent clinical studies. Am J Hypertens 26:456–464
Patel DA, Lavie CJ, Milani RV, Shah S, Gilliland Y (2009) Clinical implications of left atrial enlargement: a review. Ochsner J 9:191–196
Kizer JR, Bella JN, Palmieri V, Liu JE, Best LG, Lee ET et al (2006) Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the Strong Heart Study (SHS). Am Heart J 151:412–418
Wj M, Silverman DI, Katz SE, Douglas PS (1993) Atrial ejection force: a noninvasive assessment of atrial systolic function. J Am Coll Cardiol 22:221–225
Hesse B, Schuele SU, Thamilasaran M, Thomas J, Rodriguez L (2004) A rapid method to quantify left atrial contractile function: Doppler tissue imaging of the mitral annulus during atrial systole. Eur J Echocardiogr 5:86–92
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflict of interest to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Shin, D.G., Kang, MK., Han, D. et al. Enlarged left atrium and decreased left atrial strain are associated with atrial fibrillation in patients with hyperthyroidism irrespective of conventional risk factors. Int J Cardiovasc Imaging 38, 613–620 (2022). https://doi.org/10.1007/s10554-021-02450-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10554-021-02450-6